98%
921
2 minutes
20
The auditory brainstem response (ABR) remains the gold standard for evaluating hearing function in both animal models and humans. Features of ABR, including threshold, wave I amplitude and latency are critical for diagnosing and investigating the mechanisms of hearing loss. Critically, the rapid proliferation of genetically engineered mouse models in hearing research has created an imperative demand for high-throughput ABR testing capabilities. Currently, the Tucker-Davis Technologies (TDT) system serves as the standard, and nearly exclusive, platform for animal ABR assessment. However, the design of single-animal testing system, with low sampling rates serves as limitation to certain applications such as large-scale screening and studies of high frequency distortion product otoacoustic emission (DPOAE) and cochlear microphonic (CM). We developed a four-channel ABR system enabling simultaneous testing of four subjects, coupled with a custom acoustic chamber providing > 50 dB noise attenuation across mouse hearing frequencies. The system's enhanced acoustic and electrical performance obtains high-frequency (>32 kHz) DPOAE and CM recordings beyond the capabilities of the TDT System3 and RZ6. In mouse ABR assessments, it consistently replicates TDT-measured thresholds, wave I latency, and amplitude while tripling test throughput. This comprehensive platform meets modern high-volume ABR demands, delivering superior efficiency and expanded functional assessment for scalable, high-fidelity auditory phenotyping in next-generation research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neuroscience.2025.08.053 | DOI Listing |
Eur J Pharm Sci
September 2025
Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address:
Intratympanic (IT) delivery of dexamethasone (DEX) is widely used for treating inner ear disorders; however, its therapeutic efficacy is limited by poor permeability of the round window membrane (RWM). This study aimed to evaluate and compare the efficacy and safety of three pharmacological agents-histamine (HIS), 3% hypertonic saline (3% HS), and sodium caprate (SC)-as adjuvants for enhancing RWM permeability and improving IT-DEX delivery in a murine model. Following IT administration of each permeability enhancer followed by DEX injection, perilymph DEX concentrations were measured using ultra-high-performance liquid chromatography, and DEX receptor expression in the organ of Corti was assessed by immunofluorescence.
View Article and Find Full Text PDFJ Glob Antimicrob Resist
September 2025
Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Electronic address:
Objectives: Non-prescription supply of antibiotics in community drug retail outlets (CDROs) significantly contributes to antibiotic resistance (ABR). This study aimed to assess the effectiveness of educational intervention for pharmacy practitioners (PPs) in reducing over-the-counter (OTC) antibiotic sales.
Methods: From August 1, 2022 to January 30, 2023 a total of 80 simulated client (SC) visits (40 pre-intervention; 40:post-intervention) were made in 40 CDROs of Bahir Dar city, to determine the baseline and post-intervention extent of OTC sale of antibiotics.
Neuroscience
September 2025
Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China. Electronic address:
The auditory brainstem response (ABR) remains the gold standard for evaluating hearing function in both animal models and humans. Features of ABR, including threshold, wave I amplitude and latency are critical for diagnosing and investigating the mechanisms of hearing loss. Critically, the rapid proliferation of genetically engineered mouse models in hearing research has created an imperative demand for high-throughput ABR testing capabilities.
View Article and Find Full Text PDFObjective: This study aims to evaluate long-term auditory outcomes in patients with inner ear malformations (IEMs) treated with cochlear or auditory brainstem implants (CI/ABI), and to assess the influence of anatomical subtype, electrode design, insertion depth, and genetic/syndromic background on hearing performance over a 10-year follow-up.
Methods: We conducted a prospective cohort study including patients with radiologically confirmed IEMs and bilateral severe-to-profound hearing loss, all of whom underwent implantation and completed at least 10 years of follow-up. Outcomes were assessed using pure-tone average (PTA) and speech recognition scores (SRS) at defined intervals.
Int J Pediatr Otorhinolaryngol
August 2025
Animal Research Center, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
Background: Acoustic trauma is a process in which the sound energy coming into the ear is so high that it causes hearing loss. Although various treatments have entered clinical practice today, studies on the prevention and treatment of acoustic trauma continue. In our study, we investigated the protective and therapeutic effects of CoQ10 in rats with hearing loss due to acoustic trauma.
View Article and Find Full Text PDF